Details der Publikation - A Phase 3 study, blinded in vaccinated and unvaccinated adults to determine the safety and immune response of AZD2816, a vaccine for the prevention of COVID-19 caused by variant strains

A Phase 3 study, blinded in vaccinated and unvaccinated adults to determine the safety and immune response of AZD2816, a vaccine for the prevention of COVID-19 caused by variant strains : A Phase II/III Partially Double-Blinded, Randomised, Multinational, Active-Controlled Study in Both Previously Vaccinated and Unvaccinated Adults to Determine the Safety and Immunogenicity of AZD2816, a Vaccine for the Prevention of COVID-19 Caused by Variant Strains of SARS-CoV-2

Medienart:	Klinische Studie

Erscheinungsjahr:	2021
Erschienen:	2021

Enthalten in:	WHO International Clinical Trials Registry Platform - (2021) vom: 13. Dez. Zur Gesamtaufnahme - year:2021

Sprache:	Englisch

Links:	Volltext [kostenfrei]

Themen:	610 Medical Condition: SARS-COV-2 infection (COVID-19) MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] Phase: Phase 2 Recruitment Status: Authorised-recruitment may be ongoing or finished Study Type: Interventional

Anmerkungen:	WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 28-06-2021, Last updated: 2022-11-24

ICTRP ID:	EUCTR2021-002530-17-PL D7220C00001

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	WHO00797275X

Internformat


LEADER	01000caa a22002652 4500
001	WHO00797275X
003	DE-627
005	20230425181213.0
007	cr uuu---uuuuu
008	211103s2021 xx \|\|\|\|\|o 00\| \|\|eng c
035			\|a (DE-627)WHO00797275X
035			\|a (UBBS_Klinische_Studien_WHO)EUCTR2021-002530-17-PL
035			\|a (UBBS_Klinische_Studien_WHO)D7220C00001
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a A Phase 3 study, blinded in vaccinated and unvaccinated adults to determine the safety and immune response of AZD2816, a vaccine for the prevention of COVID-19 caused by variant strains \|b A Phase II/III Partially Double-Blinded, Randomised, Multinational, Active-Controlled Study in Both Previously Vaccinated and Unvaccinated Adults to Determine the Safety and Immunogenicity of AZD2816, a Vaccine for the Prevention of COVID-19 Caused by Variant Strains of SARS-CoV-2
264		1	\|c 2021
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 28-06-2021, Last updated: 2022-11-24
650		4	\|a Medical Condition: SARS-COV-2 infection (COVID-19) MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
650		4	\|a Study Type: Interventional
650		4	\|a Phase: Phase 2
650		4	\|a Recruitment Status: Authorised-recruitment may be ongoing or finished
650		4	\|a 610
773	0	8	\|i Enthalten in \|t WHO International Clinical Trials Registry Platform \|g (2021) vom: 13. Dez.
773	1	8	\|g year:2021 \|g day:13 \|g month:12
856	4	0	\|u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-002530-17 \|z kostenfrei \|3 Volltext
912			\|a GBV_CTG
912			\|a SSG-OLC-PHA
951			\|a AR
952			\|j 2021 \|b 13 \|c 12

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände